


Professor of Dermatological Oncology, University Hospital Würzburg | Former fellow @CarlHJune lab at UPenn | #CART #melanoma


In vivo CAR-T cell therapy nature.com/articles/s41573-0… rdcu.be/eI7zH This new Review discusses how technological advances that remove the need for ex vivo manipulation and chemotherapeutic conditioning could enable wider application of CAR-T cell therapies

In Science, researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells. The approach showed rapid and sustained immune reprogramming in preclinical models, highlighting its promise for treating cancer and autoimmune diseases. 📄: scim.ag/3TuHwJ3 #SciencePerspective: scim.ag/3SXG15Z

Treating the untreatable - "Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure" @PennMedicine @nejm #immunotherapy nejm.org/doi/full/10.1056/NE…

The April issue is live, with a focus on cancer immunotherapy nature.com/nbt/volumes/43/is… On the cover, recent clinical trials and patient reports have found promising outcomes of locoregional administration of CAR T cells across different solid tumors go.nature.com/3Z4eBiQ

Excited to share my PhD thesis work with @CarlHJune now out as a preprint on bioRxiv! We show that engineering IL-9 signaling enhances CAR T cell antitumor efficacy by steering them toward potent memory and effector states. biorxiv.org/content/10.1101/…

IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing anti-tumor efficacy doi.org/10.1101/2025.01.30.6… @carlhjune @msofiacastelli

CAR T cells have cured cancer for many patients. But the current treatment process is a laborious (and expensive) one. That's why @carlhjune teamed up with @WeissmanLab to explore using #mRNAvaccines to help a patient's own body create the #CARTcells needed to fight cancer.

Grateful to be named a 2024 RISE Scholar by @parkerici, alongside this incredible group of researchers driving advancements in cancer immunotherapy. Honored to be part of this effort toward a future where all cancers are curable!
We are thrilled to share the 2024 class of Representation in SciencE (RISE) Scholars, a group of seven exceptional researchers selected through our Diversity, Equity, Inclusion and Belonging (DEIB) Program. Read our latest blog: parkerici.org/the-latest/par…

Published today @NatureBiotech: @CarlHJune and I reveal how CAR T cells are finally tackling solid tumors! @PennPPA @PennMDForum nature.com/articles/s41587-0…

CAR T cell #immunotherapy in autoimmune disease- the origin story and current status @ScienceMagazine science.org/content/article/…

Look beyond blood. 🩸 Read about Drs. @UgiUslu and @CarlHJune's perspective on expanding CAR-T cells to solid tumors in @NatureBiotech. go.nature.com/4hROdjj

CAR T cell therapy breakthroughs bring new hope for treating solid tumors #NBTintheNews news-medical.net/news/202411…

NEW! Beyond the blood: expanding CAR T cell therapy to solid tumors @NatureBiotech @UgiUslu @carlhjune nature.com/articles/s41587-0…

Beyond the blood: expanding CAR T cell therapy to solid tumors - @UgiUslu @carlhjune go.nature.com/3Z4eBiQ

For free access to the article, please use the following link: rdcu.be/dZWb1